Connect with us


NEWS

Russia on the verge of saving the world — Putin

Published

on

Russia on the verge of saving the world -- Putin

Russia could be on the verge of saving humanity — Vladimir Putin believes as first cancer vaccines by Russia set to be made public.

It would be a human miracle the day science defeats Cancer, and if Russia’s president Vladimir Putin is to be believed, that day may just about be on the corner.

On Wednesday, February 14th, the Russian president revealed that Russian scientists are on the verge of developing vaccines for cancer, a breakthrough that could potentially revolutionize cancer treatment worldwide.

During a televised statement at a future technology symposium in Moscow, Putin expressed optimism about the progress made by Russian researchers in the development of what he referred to as “cancer vaccines and immunomodulatory drugs of a new generation.”

He emphasized the closeness of these advancements, expressing hope that they would soon become effective tools for individualized cancer therapy.

While Putin did not specify the types of cancer targeted by these proposed vaccines or the methods of administration, his remarks underscored the promising trajectory of cancer research in Russia.

The announcement comes amidst a global landscape of intensified efforts in cancer vaccine development.

Russia on the verge of saving the world -- Putin

In the United Kingdom, for instance, the government recently partnered with Germany-based BioNTech to initiate clinical trials aimed at providing personalized cancer treatments, with a goal of reaching 10,000 patients by 2030.

Meanwhile, pharmaceutical giants Moderna and Merck & Co are actively pursuing the development of an experimental cancer vaccine.

Results from a mid-stage study showed promising outcomes, indicating a significant reduction in the likelihood of recurrence or mortality from melanoma, the most lethal form of skin cancer, after three years of treatment.

Additionally, the World Health Organization reports that there are currently six licensed vaccines targeting human papillomaviruses (HPV), which are implicated in numerous cancers, including cervical cancer.

Furthermore, vaccines against hepatitis B (HBV), a known precursor to liver cancer, are also available.

Trending